Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medirom Healthcare Technologies (MRM) Liabilities and Shareholders Equity (2019 - 2025)

Historic Liabilities and Shareholders Equity for Medirom Healthcare Technologies (MRM) over the last 7 years, with Q2 2025 value amounting to $55.3 million.

  • Medirom Healthcare Technologies' Liabilities and Shareholders Equity rose 4762.61% to $55.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $192.2 million, marking a year-over-year increase of 939.43%. This contributed to the annual value of $53.2 million for FY2024, which is 1485.28% up from last year.
  • Medirom Healthcare Technologies' Liabilities and Shareholders Equity amounted to $55.3 million in Q2 2025, which was up 4762.61% from $53.2 million recorded in Q4 2024.
  • In the past 5 years, Medirom Healthcare Technologies' Liabilities and Shareholders Equity registered a high of $55.3 million during Q2 2025, and its lowest value of $6.3 million during Q3 2021.
  • In the last 5 years, Medirom Healthcare Technologies' Liabilities and Shareholders Equity had a median value of $46.9 million in 2021 and averaged $43.1 million.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first tumbled by 1532.93% in 2024, then surged by 4762.61% in 2025.
  • Quarter analysis of 5 years shows Medirom Healthcare Technologies' Liabilities and Shareholders Equity stood at $50.6 million in 2021, then dropped by 5.63% to $47.8 million in 2022, then decreased by 2.98% to $46.3 million in 2023, then increased by 14.85% to $53.2 million in 2024, then increased by 3.84% to $55.3 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $55.3 million for Q2 2025, versus $53.2 million for Q4 2024 and $37.4 million for Q2 2024.